Core Viewpoint - Metagenomi, Inc. is set to present at the 43rd Annual J.P. Morgan Healthcare Conference, highlighting its commitment to developing curative therapeutics through its proprietary gene editing toolbox [1]. Company Overview - Metagenomi is a precision genetic medicines company focused on curative therapeutics using a comprehensive metagenomics-derived toolbox [3]. - The company utilizes metagenomics to explore four billion years of microbial evolution, aiming to discover novel editing tools for correcting genetic mutations across the genome [3]. - Its genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and CAST [3]. - Metagenomi believes its diverse and modular toolbox allows access to the entire genome, optimizing genome editing potential for patients [3]. Event Details - Brian C. Thomas, PhD, CEO and founder of Metagenomi, will present on January 15, 2025, at 4:30 p.m. PT in San Francisco [1]. - A live webcast of the presentation will be available on the company's investor website, with a replay accessible for a limited time [2].
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference